iBio Inc <IBIO.O>: H.C. Wainwright initiates coverage with buy rating; target price $7
IBIO•Related News
Salesforce, Inc. <CRM.N>: BMO raises target price to $285 from $260
CRM•
Linkage Global announces 23-for-1 share consolidation to regain Nasdaq compliance
UZX•
Core Scientific Inc. <CORZ.O>: Wells Fargo initiates coverage with overweight rating and target price $28
CORZ•
LSB Industries director Jonathan Z. Ackerman acquires USD 11,300 in common shares
LXU•
Shares and short-term yields edge up after Fed hike, focus turns to BoE
SPY•